Humphrey Fonge

2.0k total citations
67 papers, 1.5k citations indexed

About

Humphrey Fonge is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Humphrey Fonge has authored 67 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Radiology, Nuclear Medicine and Imaging, 27 papers in Molecular Biology and 26 papers in Oncology. Recurrent topics in Humphrey Fonge's work include Monoclonal and Polyclonal Antibodies Research (30 papers), Radiopharmaceutical Chemistry and Applications (27 papers) and HER2/EGFR in Cancer Research (15 papers). Humphrey Fonge is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (30 papers), Radiopharmaceutical Chemistry and Applications (27 papers) and HER2/EGFR in Cancer Research (15 papers). Humphrey Fonge collaborates with scholars based in Canada, Belgium and Cuba. Humphrey Fonge's co-authors include Raymond M. Reilly, Christine Allen, Bryan Hoang, Helen Lee, C. Ronald Geyer, Kris Barreto, Guy Bormans, Alfons Verbruggen, Wendy Bernhard and Wayne Hill and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Cancer Research.

In The Last Decade

Humphrey Fonge

65 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Humphrey Fonge Canada 23 614 574 451 427 310 67 1.5k
Hsin-Ell Wang Taiwan 23 464 0.8× 506 0.9× 333 0.7× 368 0.9× 211 0.7× 69 1.4k
Anders E. Hansen Denmark 23 427 0.7× 413 0.7× 539 1.2× 546 1.3× 130 0.4× 61 1.4k
Yoshikatsu Koga Japan 24 271 0.4× 870 1.5× 409 0.9× 300 0.7× 576 1.9× 69 1.7k
Dengfeng Cheng China 24 541 0.9× 740 1.3× 410 0.9× 576 1.3× 287 0.9× 125 2.1k
Yongkang Gai China 25 363 0.6× 624 1.1× 362 0.8× 679 1.6× 508 1.6× 96 1.8k
Donald T. Yapp Canada 25 499 0.8× 704 1.2× 210 0.5× 271 0.6× 546 1.8× 68 1.8k
Piyush Kumar Canada 23 657 1.1× 486 0.8× 170 0.4× 325 0.8× 140 0.5× 82 1.7k
Tae Sup Lee South Korea 24 453 0.7× 842 1.5× 304 0.7× 464 1.1× 346 1.1× 81 2.0k
Jesper Tranekjær Jørgensen Denmark 19 552 0.9× 496 0.9× 167 0.4× 270 0.6× 224 0.7× 50 1.3k
Bart S. Hendriks United States 26 580 0.9× 1.1k 1.9× 706 1.6× 610 1.4× 785 2.5× 64 2.3k

Countries citing papers authored by Humphrey Fonge

Since Specialization
Citations

This map shows the geographic impact of Humphrey Fonge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Humphrey Fonge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Humphrey Fonge more than expected).

Fields of papers citing papers by Humphrey Fonge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Humphrey Fonge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Humphrey Fonge. The network helps show where Humphrey Fonge may publish in the future.

Co-authorship network of co-authors of Humphrey Fonge

This figure shows the co-authorship network connecting the top 25 collaborators of Humphrey Fonge. A scholar is included among the top collaborators of Humphrey Fonge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Humphrey Fonge. Humphrey Fonge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Barok, Márk, Heikki Joensuu, Natalie Zeytuni, et al.. (2025). Integrating Biochemical and Computational Approaches Reveal Structural Insights in Trastuzumab scFv-Fc Antibody Engineering. Biomolecules. 15(5). 606–606.
4.
Monzer, Alissar, et al.. (2025). 225 Ac/ 89 Zr-Labeled N4MU01 Radioimmunoconjugates as Theranostics Against Nectin-4–Positive Triple-Negative Breast Cancer. Journal of Nuclear Medicine. 66(4). 592–598. 3 indexed citations
5.
Monzer, Alissar, Neda Shafiabadi Hassani, Brian D. Gray, et al.. (2024). Preclinical safety and effectiveness of a long-acting somatostatin analogue [225Ac]Ac-EBTATE against small cell lung cancer and pancreatic neuroendocrine tumors. European Journal of Nuclear Medicine and Molecular Imaging. 52(4). 1305–1320. 2 indexed citations
6.
Fonge, Humphrey, et al.. (2024). Effectiveness of225Ac-Labeled Anti-EGFR Radioimmunoconjugate in EGFR-Positive Kirsten Rat Sarcoma Viral Oncogene and BRAF Mutant Colorectal Cancer Models. Journal of Nuclear Medicine. 65(3). 402–408. 7 indexed citations
7.
Alwani, Saniya, et al.. (2023). Biodistribution of nanodiamonds is determined by surface functionalization. Diamond and Related Materials. 137. 110071–110071. 4 indexed citations
8.
Fonge, Humphrey, et al.. (2023). Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics. British Journal of Cancer. 129(1). 153–162. 9 indexed citations
9.
Alizadeh, Elahe, Khan Behlol Ayaz Ahmed, V. Raja Solomon, et al.. (2021). 89Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In Vivo. Cancers. 13(3). 560–560. 9 indexed citations
10.
Cawthray, Jacqueline F., et al.. (2020). Production and Semi-Automated Processing of 89Zr Using a Commercially Available TRASIS MiniAiO Module. Molecules. 25(11). 2626–2626. 13 indexed citations
12.
Bernhard, Wendy, et al.. (2019). Near infrared imaging of epidermal growth factor receptor positive xenografts in mice with domain I/II specific antibody fragments. Theranostics. 9(4). 974–985. 10 indexed citations
13.
14.
Solomon, V. Raja, Carolina González, Elahe Alizadeh, et al.. (2018). 99mTc(CO)3+ labeled domain I/II-specific anti-EGFR (scFv)2 antibody fragment for imaging EGFR expression. European Journal of Medicinal Chemistry. 157. 437–446. 10 indexed citations
15.
Fonge, Humphrey, et al.. (2013). Estrone-3-Sulphate, a Potential Novel Ligand for Targeting Breast Cancers. PLoS ONE. 8(5). e64069–e64069. 14 indexed citations
16.
Chattopadhyay, Niladri, Humphrey Fonge, Zhongli Cai, et al.. (2012). Role of Antibody-Mediated Tumor Targeting and Route of Administration in Nanoparticle Tumor Accumulation in Vivo. Molecular Pharmaceutics. 9(8). 2168–2179. 82 indexed citations
17.
Saint‐Hubert, Marijke De, Felix M. Mottaghy, Kathleen Vunckx, et al.. (2010). Site-specific labeling of 'second generation' annexin V with Tc-99m(CO)(3) for improved imaging of apoptosis in vivo. Research Publications (Maastricht University). 28 indexed citations
18.
Lee, Helen, Humphrey Fonge, Bryan Hoang, Raymond M. Reilly, & Christine Allen. (2010). The Effects of Particle Size and Molecular Targeting on the Intratumoral and Subcellular Distribution of Polymeric Nanoparticles. Molecular Pharmaceutics. 7(4). 1195–1208. 283 indexed citations
19.
Chitneni, Satish K., Kim Serdons, Nele Evens, et al.. (2007). Efficient purification and metabolite analysis of radiotracers using high-performance liquid chromatography and on-line solid-phase extraction. Journal of Chromatography A. 1189(1-2). 323–331. 22 indexed citations
20.
Fonge, Humphrey, Kathleen Vunckx, Hao Wang, et al.. (2007). Non-invasive detection and quantification of acute myocardial infarction in rabbits using mono-[123I]iodohypericin  SPECT. European Heart Journal. 29(2). 260–269. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026